Abridge

Abridge raises $300M Series E funding round led by a16z, and joined by Khosla Ventures to pioneer a new paradigm of care with intelligence at the point of conversation. 🚀 David George, 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗮𝘁 𝗔𝗻𝗱𝗿𝗲𝗲𝘀𝘀𝗲𝗻 𝗛𝗼𝗿𝗼𝘄𝗶𝘁𝘇: “Abridge eliminates inefficiencies at their source, directly in the clinical conversation, with a platform that has demonstrated tremendous traction and impact in the market. This is a company with truly rare ingredients: world-class clinical and technical leadership, deep scientific credibility, and AI technology that is years ahead of the field. Abridge has both the vision and velocity to create lasting, systemic change, and we are thrilled to be part of their journey.” Abridge is now deployed at 𝟭𝟱𝟬 𝗲𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 and will support more than 𝟱𝟬 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 this year alone, across specialties, care settings from outpatient to ERs to inpatient workflows—all with 𝗰𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻 𝗿𝗲𝘁𝗲𝗻𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝗼𝗳 𝗼𝘃𝗲𝗿 𝟵𝟬%. This is a new standard for delivering impact at scale for enterprise-grade AI in healthcare, and it’s just the beginning. Read more here:

14,466 просмотров